| Primary information |
|---|
| ID | 11671 |
| Uniprot ID | P55089 |
| Description | Urocortin |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the sauvagine/corticotropin-releasing factor/urotensin I family. |
| Tissue Specificity | Keratinocytes in epidermis and the outer and inner root sheaths of hair follicles; epithelium of sebaceous and sweat glands; erector pili muscle; cutaneous blood vessel walls; cutaneous nerves and der |
| Post Translational Modification | NA |
| Function | Acts in vitro to stimulate the secretion of adrenocorticotropic hormone (ACTH) |
| Length | 124 |
| Molecular Weight | 13 |
| Name | Urocortin |
| Sequence | DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV |
| Sequence map | 40 |
| PDB ID | 2RMF; 3N96; 6PB0; 6PB1; |
| Drugpedia | NA |
| Receptor | P34998; Q13324; Q13324-2 |
| Domain | NA |
| Pharmaceutical Use | NA
|